Cargando…
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
Aberrant SRC expression and activation is frequently detected in multiple cancers, and hence, targeting SRC has emerged as a promising therapeutic strategy. Different SRC inhibitors have demonstrated potent anti-tumor activity in preclinical models, although they largely lack clinical efficacy as mo...
Autores principales: | Hermida-Prado, Francisco, Granda-Díaz, Rocío, del-Río-Ibisate, Nagore, Villaronga, M. Ángeles, Allonca, Eva, Garmendia, Irati, Montuenga, Luis M., Rodríguez, René, Vallina, Aitana, Alvarez-Marcos, César, Rodrigo, Juan P., García-Pedrero, Juana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896085/ https://www.ncbi.nlm.nih.gov/pubmed/31731442 http://dx.doi.org/10.3390/cancers11111644 |
Ejemplares similares
-
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
por: Hermida-Prado, Francisco, et al.
Publicado: (2019) -
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
por: Hermida-Prado, Francisco, et al.
Publicado: (2018) -
Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets
por: Álvarez-Teijeiro, Saúl, et al.
Publicado: (2018) -
Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas
por: Rodrigo, Juan P., et al.
Publicado: (2015) -
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)